المؤلفون: Pudil, R., Mueller, C., Celutkiene, J., Henriksen, P.A., Lenihan, D., Dent, S., Barac, A., Stanway, S., Moslehi, J., Suter, T.M., Ky, B., Sterba, M., Cardinale, D., Cohen-Solal, A., Tocchetti, C.G., Farmakis, D., Bergler-Klein, J., Anker, M.S., Haehling, S. von, Belenkov, Y., Iakobishvili, Z., Maack, C., Ciardiello, F., Ruschitzka, F., Coats, A.J.S., Seferovic, P., Lainscak, M., Piepoli, M.F., Chioncel, O., Bax, J., Hulot, J.S., Skouri, H., Hagler-Laube, E.S., Asteggiano, R., Fernandez, T.L., Boer, R.A. de, Lyon, A.R.

المصدر: European Journal of Heart Failure

مصطلحات موضوعية: Biomarkers, Cardio-oncology, Cardiotoxicity, Heart failure, Myocarditis, Cardiac troponin, B-type natriuretic peptides, Anthracyclines, HER2-targeted therapies, Vascular endothelial growth factor inhibitors, Proteasome inhibitors, Immune checkpoint inhibitors, Radiotherapy

وصف الملف: application/pdf

العلاقة: lumc-id: 115690100; https://hdl.handle.net/1887/3232672Test

الإتاحة: https://doi.org/10.1002/ejhf.2017Test
https://hdl.handle.net/1887/3232672Test

المؤلفون: Ameri, P, Canepa, M, Anker, MS, Belenkov, Y, Bergler-Klein, J, Cohen-Solal, A, Farmakis, D, López-Fernández, T, Lainscak, M, Pudil, R, Ruschitska, F, Seferovic, P, Filippatos, G, Coats, A, Suter, T, Von Haehling, S, Ciardiello, F, De Boer, RA, Lyon, AR, Tocchetti, CG, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology

المساهمون: Ameri, Pietro, Canepa, Marco, Anker, Markus S., Belenkov, Yury, Bergler-Klein, Jutta, Cohen-Solal, Alain, Farmakis, Dimitrio, López-Fernández, Teresa, Lainscak, Mitja, Pudil, Radek, Ruschitska, Frank, Seferovic, Petar, Filippatos, Gerasimo, Coats, Andrew, Suter, Thoma, Von Haehling, Stephan, Ciardiello, Fortunato, de Boer, Rudolf A., Lyon, Alexander R., Tocchetti, Carlo G.

المصدر: European Journal of Heart Failure. 20(5):879-887

مصطلحات موضوعية: Cardiac & Cardiovascular Systems, medicine.medical_treatment, Co-morbidity, Comorbidity, 030204 cardiovascular system & hematology, Global Health, Targeted therapy, Androgen deprivation therapy, Prostate cancer, 0302 clinical medicine, TARGETED THERAPY, RENAL-CELL CARCINOMA, Neoplasms, Epidemiology, INCREASED RISK, AMERICAN SOCIETY, Cancer, Heart failure, Prognosis, Therapy, Cardiology and Cardiovascular Medicine, ORAL ANTICOAGULANTS, Incidence (epidemiology), Incidence, Disease Management, 3. Good health, PROSTATE-CANCER, Survival Rate, PRACTICE GUIDELINES, 030220 oncology & carcinogenesis, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology, Life Sciences & Biomedicine, Diagnostic Imaging, medicine.medical_specialty, Prognosi, LONG-TERM, Malignancy, 1102 Cardiovascular Medicine And Haematology, 03 medical and health sciences, Breast cancer, medicine, Humans, BREAST-CANCER, Intensive care medicine, TERM-FOLLOW-UP, EUROPEAN ASSOCIATION, Science & Technology, business.industry, medicine.disease, MYOCARDIAL-INFARCTION, Cardiovascular System & Hematology, ATRIAL-FIBRILLATION, Cardiovascular System & Cardiology, ANDROGEN DEPRIVATION THERAPY, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ae5221f0ca1c551bc118d061e00b74Test
https://hdl.handle.net/11370/4cad5946-19a3-4022-8749-fb5e2127683fTest